Challenges and future of precision medicine strategies for breast cancer based on a database on drug reactions
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Challenges and future of precision medicine strategies for breast cancer based on a database on drug reactions
Authors
Keywords
-
Journal
BIOSCIENCE REPORTS
Volume 39, Issue 9, Pages BSR20190230
Publisher
Portland Press Ltd.
Online
2019-08-07
DOI
10.1042/bsr20190230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment
- (2018) Katja Pinker et al. RADIOLOGY
- Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling
- (2017) Kai Zhang et al. GENE
- Biomarkers of Everolimus Sensitivity in Hormone Receptor-Positive Breast Cancer
- (2017) Zongbi Yi et al. Journal of Breast Cancer
- Precision medicine in breast cancer: reality or utopia?
- (2017) Ali Bettaieb et al. Journal of Translational Medicine
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptomics technologies
- (2017) Rohan Lowe et al. PLoS Computational Biology
- GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer
- (2016) Zheqiong Yang et al. AMERICAN JOURNAL OF PATHOLOGY
- Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol
- (2016) Jessica A. Martinez et al. BMC CANCER
- Germline RECQL mutations in high risk Chinese breast cancer patients
- (2016) Ava Kwong et al. BREAST CANCER RESEARCH AND TREATMENT
- Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer
- (2016) Kaijiong Zhang et al. Cancer Biomarkers
- High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer
- (2016) Gaëlle Judes et al. CANCER LETTERS
- PALB2,CHEK2andATMrare variants and cancer risk: data from COGS
- (2016) Melissa C Southey et al. JOURNAL OF MEDICAL GENETICS
- Perspective: The precision-oncology illusion
- (2016) Vinay Prasad NATURE
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- (2016) Serena Nik-Zainal et al. NATURE
- Limits to Personalized Cancer Medicine
- (2016) Ian F. Tannock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uncertainty in the Era of Precision Medicine
- (2016) David J. Hunter NEW ENGLAND JOURNAL OF MEDICINE
- GIPS: A Software Guide to Sequencing-Based Direct Gene Cloning in Forward Genetics Studies
- (2016) Han Hu et al. PLANT PHYSIOLOGY
- Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its Fe-S clusters
- (2016) Merav Darash-Yahana et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA-Seq methods for transcriptome analysis
- (2016) Radmila Hrdlickova et al. Wiley Interdisciplinary Reviews-RNA
- Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial
- (2015) A. DeCensi et al. Cancer Prevention Research
- The Precision Medicine Initiative
- (2015) Euan A. Ashley JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials
- (2015) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer
- (2015) Ana Bosch et al. Science Translational Medicine
- Precision Medicine in Breast Cancer: Genes, Genomes, and the Future of Genomically Driven Treatments
- (2015) Daniel G. Stover et al. Current Oncology Reports
- Chloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer
- (2014) K. L. Cook et al. CLINICAL CANCER RESEARCH
- Breast cancer in China
- (2014) Lei Fan et al. LANCET ONCOLOGY
- Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
- (2014) Fabrice André et al. LANCET ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Human interactome resource and gene set linkage analysis for the functional interpretation of biologically meaningful gene sets
- (2013) Xi Zhou et al. BIOINFORMATICS
- Omic-profiling in breast cancer metastasis to bone: Implications for mechanisms, biomarkers and treatment
- (2013) Steven L. Wood et al. CANCER TREATMENT REVIEWS
- “Omics” of HER2-Positive Breast Cancer
- (2013) Valentina Bravatà et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- TargetingmiR-205in breast cancer
- (2009) Hailong Wu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- RNA-Seq: a revolutionary tool for transcriptomics
- (2008) Zhong Wang et al. NATURE REVIEWS GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started